This inventor holds 24 USPTO granted patents and 23 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Immunotherapy Technologies. Top assignees: Regeneron Pharmaceuticals, Inc., 2Seventy Bio, Inc., Bluebird Bio, Inc.. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
8 out of 1,484 
7 out of 24 
6 out of 35 
Years Active: 2018-2026
Areas of Expertise:
Title: Innovator Spotlight - Jordan Jarjour: Pioneering Genome Editing Advancements
Introduction:
Jordan Jarjour, a distinguished innovator based in Seattle, WA, has made significant contributions to the field of genome editing with his groundbreaking patents and research. With a robust portfolio of 14 patents, Jarjour is at the forefront of developing cutting-edge technologies for the prevention and treatment of various diseases.
Latest Patents:
Jarjour's latest patents showcase his expertise in genome editing technologies. One of his recent inventions includes PD-1 homing endonuclease variants, compositions, and methods of use. This innovation offers improved genome editing tools for editing the PD-1 gene, aiming to address cancer, infectious diseases, autoimmune diseases, and other health conditions. Additionally, his work on PCSK9 endonuclease variants provides novel approaches for editing the PCSK9 gene to combat hypercholesterolemia and related disorders.
Career Highlights:
Throughout his career, Jarjour has made significant strides in the biotechnology industry. He has notably worked at renowned companies such as 2Seventy Bio, Inc. and Bluebird Bio, Inc., where he has spearheaded research and development efforts in the field of genetic engineering and genome editing. His innovative thinking and dedication to advancing science have solidified his reputation as a trailblazer in the industry.
Collaborations:
Collaboration plays a key role in Jarjour's success, with notable partnerships with industry experts such as Alexander Astrakhan and Michael Certo. By working alongside top minds in the field, Jarjour has been able to leverage collective knowledge and expertise to push the boundaries of genome editing technologies and drive impactful change in healthcare and biotechnology.
Conclusion:
In conclusion, Jordan Jarjour stands as a visionary inventor whose work in genome editing continues to redefine possibilities in healthcare and biotechnology. With a wealth of patents and a track record of innovation, Jarjour's contributions have the potential to revolutionize the way we approach disease prevention and treatment. His passion for discovery and commitment to scientific excellence mark him as a standout figure in the realm of cutting-edge research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile